Pulse Biosciences is a bioelectric medicine company pursuing commercial introduction of our proprietary CellFX⢠System utilizing our patented Nano-Pulse Stimulation⢠(NPSâ˘) technology. The unique cell-specific effects of the NPS mechanism of action have the potential to significantly benefit patients across multiple medical applications, including dermatology, our first planned commercial application. To date, we own or have a license to more than 94 issued patents worldwide. With this growing patent portfolio surrounding our innovative technology, Pulse Biosciences seeks to aggressively realize the potential of Nano-Pulse Stimulation technology, building a rich pipeline of transformative commercial applications. From the launch of our first planned commercial offering, the CellFX System, to our current ongoing clinical studies, to the planned studies that fuel our rich pipeline, we see a clear path to the future as Pulse Biosciences brings the promise of NPS technology from the lab to lives of real patients today, and tomorrow. Source
No articles found.
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy ...
Atara Biotherapeutics is a leading off-the-shel...
The Exponent name is recognized for its integrity, objectivity, independence, and ...
The Exponent name is recognized for its integri...
Forty Seven is a clinical-stage immuno-oncology company focused on developing nove...
Forty Seven is a clinical-stage immuno-oncology...
Biomerica, Inc. is a global biomedical company that develops, manufactures and mar...
Biomerica, Inc. is a global biomedical company ...
Bio-Path is a biotechnology company developing targeted therapies for acute myeloi...
Bio-Path is a biotechnology company developing ...
Intellia Therapeutics is a leading genome editing company focused on developing cu...
Intellia Therapeutics is a leading genome editi...
Predictive Oncology is a clinical and translational data pipeline and AI-driven pl...
Predictive Oncology is a clinical and translati...
Join the National Investor Network and get the latest information with your interests in mind.